Literature DB >> 21500882

Set shifting in a rodent model of attention-deficit/hyperactivity disorder.

Amy C Chess1, Brittany E Raymond, Ira G Gardner-Morse, Mark R Stefani, John T Green.   

Abstract

Two experiments compared spontaneously hypertensive rats (SHRs; a rodent model of attention-deficit/hyperactivity disorder) and Wistar rats (a normoactive control strain), on the acquisition of a set-shifting strategy. In Experiment 1, SHRs and Wistar rats were equivalent in trials to criterion to learn a brightness or a texture discrimination but SHRs were faster than Wistar rats in shifting to the opposite discrimination when there was 1 or 2 days between the initial discrimination and the shift. In Experiment 2, SHRs and Wistar rats were equivalent in shifting when the shift between discriminations occurred immediately after a criterion had been met in the first discrimination. The results are discussed in terms of a failure of SHRs to store or retrieve an initial discrimination and/or latent inhibition over a delay, leading to faster acquisition of a set-shift. This failure in storage or retrieval may be the result of a hypoactive dopamine system in the prefrontal cortex and nucleus accumbens shell as well as abnormalities in entorhinal cortex in SHRs.

Entities:  

Mesh:

Year:  2011        PMID: 21500882      PMCID: PMC3109168          DOI: 10.1037/a0023571

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  71 in total

Review 1.  The Wisconsin Card Sorting Test and the cognitive assessment of prefrontal executive functions: a critical update.

Authors:  Erika Nyhus; Francisco Barceló
Journal:  Brain Cogn       Date:  2009-04-17       Impact factor: 2.310

2.  To act or not to act, that's the problem: primarily inhibition difficulties in adult ADHD.

Authors:  A Marije Boonstra; J J Sandra Kooij; Jaap Oosterlaan; Joseph A Sergeant; Jan K Buitelaar
Journal:  Neuropsychology       Date:  2010-03       Impact factor: 3.295

3.  Autoradiography of dopamine receptors and dopamine uptake sites in the spontaneously hypertensive rat.

Authors:  K Kujirai; S Przedborski; V Kostic; V Jackson-Lewis; S Fahn; J L Cadet
Journal:  Brain Res Bull       Date:  1990-11       Impact factor: 4.077

4.  6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine.

Authors:  A C Roberts; M A De Salvia; L S Wilkinson; P Collins; J L Muir; B J Everitt; T W Robbins
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

5.  The nigrostriatal dopamine system: role in the development of hypertension in spontaneously hypertensive rats.

Authors:  A C Linthorst; P L van Giersbergen; M Gras; D H Versteeg; W de Jong
Journal:  Brain Res       Date:  1994-03-14       Impact factor: 3.252

Review 6.  The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain.

Authors:  Terje Sagvolden; Espen Borgå Johansen; Grete Wøien; S Ivar Walaas; Jon Storm-Mathisen; Linda Hildegard Bergersen; Oivind Hvalby; Vidar Jensen; Heidi Aase; Vivienne A Russell; Peter R Killeen; Tania Dasbanerjee; Frank A Middleton; Stephen V Faraone
Journal:  Neuropharmacology       Date:  2009-08-19       Impact factor: 5.250

7.  Early breakdown of dendritic bundles in the retrosplenial granular cortex of hypertensive rats: prevention by antihypertensive therapy.

Authors:  J M Wyss; T Van Groen
Journal:  Cereb Cortex       Date:  1992 Nov-Dec       Impact factor: 5.357

8.  Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis.

Authors:  G J Kirouac; P K Ganguly
Journal:  Neuroscience       Date:  1993-01       Impact factor: 3.590

9.  Impaired learning and memory in mature spontaneously hypertensive rats.

Authors:  J M Wyss; G Fisk; T van Groen
Journal:  Brain Res       Date:  1992-10-02       Impact factor: 3.252

10.  Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

Authors:  V Russell; A de Villiers; T Sagvolden; M Lamm; J Taljaard
Journal:  Brain Res       Date:  1995-04-10       Impact factor: 3.252

View more
  6 in total

1.  Acute intranasal dopamine application counteracts the reversal learning deficit of spontaneously hypertensive rats in an attentional set-shifting task.

Authors:  Jay-Shake Li; Shan-Sung Yang; Joseph P Huston; Owen Y Chao; Yi-Mei Yang; Claudia Mattern
Journal:  Psychopharmacology (Berl)       Date:  2021-05-12       Impact factor: 4.530

Review 2.  Inattentiveness in attention-deficit/hyperactivity disorder.

Authors:  Ariane Sroubek; Mary Kelly; Xiaobo Li
Journal:  Neurosci Bull       Date:  2013-01-08       Impact factor: 5.203

3.  Performance on a strategy set shifting task in rats following adult or adolescent cocaine exposure.

Authors:  Kathleen M Kantak; Nicole Barlow; David H Tassin; Madeline F Brisotti; Chloe J Jordan
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

4.  Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.

Authors:  Roxann C Harvey; Chloe J Jordan; David H Tassin; Kayla R Moody; Linda P Dwoskin; Kathleen M Kantak
Journal:  Behav Brain Res       Date:  2013-01-31       Impact factor: 3.332

5.  Gonadal hormones and voluntary exercise interact to improve discrimination ability in a set-shift task.

Authors:  Meghan C Eddy; Katharine M Rifken; Donna J Toufexis; John T Green
Journal:  Behav Neurosci       Date:  2013-08-26       Impact factor: 1.912

6.  Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder.

Authors:  Ai-hua Cao; Lin Yu; Yu-wei Wang; Jun-mei Wang; Le-jin Yang; Ge-Fei Lei
Journal:  Behav Brain Funct       Date:  2012-02-28       Impact factor: 3.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.